Fluoxetine plus therapy boosts QOL in depression

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1573, 2007-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sertraline plus sleep deprivation therapy boosts QOL in MDD

Inpharma, Vol. 1, Iss. 1510, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Sertraline plus sleep deprivation therapy boosts QOL in MDD

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 489, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Fluoxetine affords QOL benefit in advanced cancer, depression

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 416, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Sertraline, fluoxetine, paroxetine: similar QOL in depression

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 345, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Sertraline, fluoxetine, paroxetine: similar QOL in depression

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite